Crossmark

Synthesis, biological evaluation, molecular docking, and MD simulation of novel 2,4-disubstituted quinazoline derivatives as selective butyrylcholinesterase inhibitors and antioxidant agents

Crossref DOI link: https://doi.org/10.1038/s41598-024-66424-z

Published Online: 2024-07-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sadeghian, Sara

Razmi, Raziyeh

Khabnadideh, Soghra

Khoshneviszadeh, Mehdi

Mardaneh, Pegah

Talashan, Arman

Pirouti, Arman

Khebre, Fatemeh

Zahmatkesh, Zahra

Rezaei, Zahra
Funding

Funding for this research was provided by:

Shiraz University of Medical Sciences (21476)
License Information

Text and Data Mining valid from 2024-07-06

Version of Record valid from 2024-07-06
More Information

Article History

Received: 13 March 2024

Accepted: 1 July 2024

First Online: 6 July 2024

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below